Fundraising Fox

Todd Verdoorn

Executive at DiaMedica Therapeutics

Hopkins, Minnesota, United States

Find your path to Todd

27 people in our graph share verified history with Todd — schools, employers, funds. One of them is your warm intro.

Bruce EvansunlockedTodd: together at Vanderbilt University Medical Center
×2Todd: together at Central College
×8Todd: together at Vanderbilt University Medical Center
Todd: together at DiaMedica Therapeutics

Executive at DiaMedica Therapeutics

Intro paths

→

In turn, Todd can intro founders to DiaMedica Therapeutics's investors below.

DiaMedica Therapeutics's investors · 2

CentreStone VenturesWinnipeg · $182.5K – $1.8M checksShepherd VenturesSan Diego · $750K – $3M checks · since 2023

Experience

  1. Intuitive QuantitationChief Scientistcurrent2013 — presentGreater Minneapolis-St. Paul Area
  2. DiaMedica Inc.Chief Scientific Officer2016 — 2019Greater Minneapolis-St. Paul Area
  3. NeuroTherapeutics Pharma, Inc.Vice President Neurobiology2011 — 2013Greater Chicago Area
  4. Orasi Medical, Inc.Chief Scientific Officer2008 — 2011Greater Minneapolis-St. Paul Area
  5. SMART BioscienceChief Scientific Officer2007 — 2008Greater Philadelphia Area
  6. Algos Preclinical Services, Inc.Chief Scientific Officer2003 — 2007Greater Minneapolis-St. Paul Area
  7. Bristol-Myers Squibb PRIDirector of Neurology Drug Discovery1997 — 2003
  8. Vanderbilt University Medical CenterAssociate Professor1991 — 1997
  9. Max Planck Institute for Medical ResearchPostdoctoral Fellow1988 — 1991Heidelberg Area, Germany

Skills & more

Translational MedicineNeuroscienceU.S. Food and Drug Administration (FDA)Statistical Data AnalysisDrug DiscoveryPharmacologyHealthcare ConsultingResearch and Development (R&D)Data ScienceClinical TrialsQuantitative ResearchBiomarker Development
+12 moreMultivariate StatisticsProduct DevelopmentResearchStart-upsClinical DevelopmentData MiningBiotechnologyDiagnostic SoftwareLifesciencesOutsourcing ManagementHardware DiagnosticsDrug Development

Languages German

From Todd's professional profile.

Frequently asked questions

Who is Todd Verdoorn?
Executive Officer at DiaMedica Therapeutics
Where does Todd Verdoorn work?
Todd Verdoorn is Executive at DiaMedica Therapeutics.
Where did Todd Verdoorn go to school?
Todd Verdoorn studied at The University of North Carolina at Chapel Hill (Ph.D., Neurobiology); Central College (BA, Chemistry).

Same school

Also attended The University of North Carolina at Chapel Hill402

Clint MyersInvestor at RevolutionMahati SridharPartner, Rise of the Rest at RevolutionEric WagnerVP of Research and Data at Redpoint VenturesSoul DayanInvestor at True VenturesAlex LimInvestor at IVP (Institutional Venture Partners)Alex TaubPrincipal at QED Investors

+ 396 more

Also attended Central College4

Rick RyanGeneral Partner at Cultivation CapitalMike TudeenInvestor at HLM Investment PartnersKirstie LuehringOffice & Communications Coordinator at ManchesterStory Group, LLCTej DhawanSenior Advisor at Next Level Ventures

Shared employers

Also worked at DiaMedica Inc.5

David J. WambekeExecutive Officer at DiaMedica TherapeuticsLorianne MasuokaExecutive Officer at DiaMedica TherapeuticsRick PaulsExecutive Officer, Director at DiaMedica TherapeuticsScott KellenExecutive Officer at DiaMedica TherapeuticsJulie KropChief Medical Officer at DiaMedica Therapeutics

Also worked at Bristol-Myers Squibb PRI120

Scott BillerInvestor at GV (Google Ventures)Avantika DaingFounding Partner at Plum Alley InvestmentsJake BauerVenture Partner at ARCH Venture PartnersScott DonohueSenior Director, Market Access at Deerfield Management CompanyMellissa GraySenior Scientist, Protein Sciences at Deerfield Management CompanyBeth SeidenbergFounding Managing Director at Westlake Village BioPartners

+ 114 more

Also worked at Vanderbilt University Medical Center20

Bruce EvansSenior Advisor and former Managing Director of Summit PartnersJonathan SadloweFounder and General Partner at Gossamer CapitalJack McGuireResearch Associate at Casdin CapitalBen ScruggsPartner at Hatteras Venture PartnersMatthew McGirtGeneral Partner at Mammoth ResearchMichihiko WadaChief Regulatory and Development Officer at Newton Biocapital

+ 14 more